Which tests measure Apolipoprotein B to Apolipoprotein A-1 Ratio?

Apolipoprotein B to Apolipoprotein A-1 Ratio is measured in 1 test on BiomarkersLabs.com, including Apolipoprotein A-1 (ApoA-1) Test.

Biomarker Reference · ApoB:ApoA-1

What does the Apolipoprotein B to Apolipoprotein A-1 Ratio test measure?

Q: Why is Apolipoprotein B to Apolipoprotein A-1 Ratio measured?

Large prospective datasets position the ApoB:ApoA-1 ratio among the strongest lipid-based discriminators of myocardial infarction risk, often outperforming conventional cholesterol fractions. It condenses the balance between pro- and anti-atherogenic particle counts into one number that is informative even when LDL-cholesterol is unremarkable, as in insulin resistance with small dense LDL.

Q: What is the reference range for Apolipoprotein B to Apolipoprotein A-1 Ratio?

The standard reference range for Apolipoprotein B to Apolipoprotein A-1 Ratio is Reported as a unitless ratio; lower values are favourable. Broadly, low-risk roughly <0.7, with higher-risk bands above ~0.9 in men and ~0.8 in women.. Reference ranges vary by laboratory and assay platform — interpret in context of the issuing laboratory's stated range.

Apolipoprotein B to Apolipoprotein A-1 Ratio (ApoB:ApoA-1) is a clinical biomarker used in cardiovascular assessment. The ratio sets the number of atherogenic, ApoB-bearing particles (LDL, VLDL, IDL, Lp(a) and remnants, one ApoB per particle) against the number of protective ApoA-1-bearing HDL particles. It is measured in 1 laboratory test on BiomarkersLabs.com.

Reference Range: Reported as a unitless ratio; lower values are favourable. Broadly, low-risk roughly <0.7, with higher-risk bands above ~0.9 in men and ~0.8 in women.
Units: ratio
Measured In: 1 test
Category: Cardiovascular

Functional medicine optimalLow-risk targets are commonly cited near <0.7 overall, with sex-specific low-risk values around <0.7 in men and <0.6 in women.

What is Apolipoprotein B to Apolipoprotein A-1 Ratio?

The ratio sets the number of atherogenic, ApoB-bearing particles (LDL, VLDL, IDL, Lp(a) and remnants, one ApoB per particle) against the number of protective ApoA-1-bearing HDL particles. It is a derived marker calculated from the two measured apolipoproteins rather than an independently assayed analyte, and it does not require fasting because neither component is meaningfully affected by a recent meal.

Why is Apolipoprotein B to Apolipoprotein A-1 Ratio measured?

Large prospective datasets position the ApoB:ApoA-1 ratio among the strongest lipid-based discriminators of myocardial infarction risk, often outperforming conventional cholesterol fractions. It condenses the balance between pro- and anti-atherogenic particle counts into one number that is informative even when LDL-cholesterol is unremarkable, as in insulin resistance with small dense LDL.

Reference ranges

Standard reference: Reported as a unitless ratio; lower values are favourable. Broadly, low-risk roughly <0.7, with higher-risk bands above ~0.9 in men and ~0.8 in women.
Functional medicine optimal: Low-risk targets are commonly cited near <0.7 overall, with sex-specific low-risk values around <0.7 in men and <0.6 in women.
Units: ratio

Reference ranges vary by laboratory and assay platform. Interpret in context of the issuing laboratory's stated range.

Tests that measure Apolipoprotein B to Apolipoprotein A-1 Ratio

1 test on BiomarkersLabs.com include this biomarker.

BML-CAR-036Comprehensive

Apolipoprotein A-1 (ApoA-1) Test

Apolipoprotein B to Apolipoprotein A-1 Ratio reference range in this test: Reported as a unitless ratio; lower values are favourable. Broadly, low-risk roughly <0.7, with higher-risk bands above ~0.9 in men and ~0.8 in women.

Related clinical conditions

Related Biomarkers

Frequently measured alongside

Apolipoprotein A-1ApoA-11 test

Order tests measuring Apolipoprotein B to Apolipoprotein A-1 Ratio for your patients

Available exclusively to verified licensed healthcare practitioners. CLIA-certified laboratory results delivered to your secure portal.